{"id":"W2685405318","doi":"10.1016/j.diabet.2017.05.005","title":"Combination avelumab and utomilumab immunotherapy can induce diabetic ketoacidosis","year":2017,"lang":"en","type":"letter","venue":"Diabetes & Metabolism","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Diabetic ketoacidosis; Avelumab; Medicine; Immunotherapy; Ketoacidosis; Diabetes mellitus; Immunology; Immunopathology; Intensive care medicine; Type 1 diabetes; Endocrinology; Immune system; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005185183,0.000808361,0.001628232,0.0005020601,0.0004149454,0.0003217645,0.0005015294,0.001272304,0.0004085859],"category_scores_gemma":[0.0001054387,0.0007316414,0.0004733103,0.0002007736,0.0005153592,0.000191224,0.0001031329,0.001805804,0.0000475688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001940278,"about_ca_system_score_gemma":0.0002507866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002734921,"about_ca_topic_score_gemma":0.000006640835,"domain_scores_codex":[0.9965614,0.0002130965,0.0006614146,0.0008955686,0.0007321655,0.0009363201],"domain_scores_gemma":[0.9973177,0.0001644173,0.0006444713,0.001500827,0.0002290912,0.0001434499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000319597,0.0002417614,0.004332964,0.0009021597,0.003351426,0.0001535107,0.001008213,4.691517e-8,0.03742814,0.00005848712,0.7298705,0.2223332],"study_design_scores_gemma":[0.006754256,0.0001929075,0.0713079,0.0004953447,0.0008012585,0.00001989234,0.00001893721,0.00002054964,0.009160781,0.0003599091,0.9100408,0.0008274824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.5926486,0.04243092,0.000003063802,0.3578425,0.002771595,0.001490917,0.0002820335,0.0001936863,0.00233663],"genre_scores_gemma":[0.2716504,0.007260157,0.0002976897,0.6948728,0.00615756,0.0005812845,0.001824803,0.0004453923,0.0169099],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.3370303,"threshold_uncertainty_score":0.9995134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01432389210079938,"score_gpt":0.2530380344837107,"score_spread":0.2387141423829113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}